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ABSTRACT 
Objective: To evaluate the distribution of cardiovas- 
cular risk factors and the prevalence of cardiovascu- 
lar disease in a sample of the Italian population. 
Methods: CHECK (Cholesterol and Health: Education, 
Control and Knowledge) is a cross-sectional observa- 
tional study in a randomised sample of the Italian 
adult population aged 40 - 79 years, in the setting of 
general practice. Results: 5846 subjects (50.3% male) 
were included in the analysis. The mean age [±SD] of 
the observed cohort was 57.8 (±10.3) years. One out 
of five subjects smoked cigarettes and almost 80% 
didn’t engage in regular leisure-time physical activity. 
The mean blood pressure was 132.0 [±14.7]/81.2 [±7.9] 
mmHg. The total and LDL-cholesterol levels were 
respectively 205.3 [±35.9] mg/dL and 124.9 [±29.9] 
mg/dL. The mean glucose concentration was 98.3 
[±28.2] mg/dL. The prevalence rate of hypertension, 
hypercholesterolemia, and type 2 diabetes were re- 
spectively 51.8%, 55.6%, and 13.0%. 8.9% of the ob- 
served subjects had a history of cardiovascular events, 
while in the primary prevention group the 10-year- 
risk of coronary heart disease (Framingham algo- 
rithm) was 10.1% [±8.3%] and of cardiovascular 
disease (CUORE algorithm) was 5.2% [±5.9%]. Con- 
clusion: The CHECK study provides a detailed de- 
scription of a randomised sample of the Italian popu- 
lation, contributing to evaluate the prevalence of car- 
diovascular risk factors and the main cardiovascular 
disease in Italy and to provide a baseline to set priori- 
ties and objectives for future intervention of health 
policy.  
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1. INTRODUCTION 
Cardiovascular diseases (CVD), a group of disorders of 
the heart and blood vessels, including coronary heart 
disease, cerebrovascular disease, peripheral arterial dis-
ease, are the leading cause of morbidity, disability and 
mortality worldwide, showing a continue increasing trend. 
In 2008, CVD caused 17 million deaths (47.2% of non- 
communicable diseases deaths, 29.8% of total deaths in 
the world) [1]; in particular, 7.6 million deaths were due 
to ischemic heart disease and 5.7 million to stroke [2]. 
CVD remains the first cause of death and disability in 
Italy although a slow and stepwise reduction of incidence 
has been observed since the mid seventies [3,4]. 
The subjects who survive acute cardiovascular events 
are likely to become chronic patients. CVD compromise 
patients’ quality of life and represent a significant eco- 
nomic burden to the national health system. Cardiovas- 
cular drugs account for about 26.4% of the Italian Phar- 
maceutical expenditure [5]. 
The CHECK (Cholesterol and Health: Education, 
Control and Knowledge) study was designed to provide 
information on the distribution of the main CVD risk 
factors in Italy setting the stage for addressing questions 
relative to the plausibility and feasibility of interventions 
on the principal risk factors for CVD in an European 
country.  
CHECK is the first randomised Italian epidemiologi- 
cal study performed in primary care. Its main objective 
was to evaluate the distribution of cardiovascular risk 
factors and the prevalence of cardiovascular disease in a 
representative sample of the Italian adult population aged 
40 - 79 years. Other aims were 1) to perform a follow-up 
study to determine the incidence of cardiovascular events 
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and other main pathologies, 2) to create plasma and 
DNA banks to design ad-hoc nested case-control studies, 
3) to disseminate information about cardiovascular risk 
factors to increase physicians and patients awareness and 
contribute to the implementation of evidences supporting 
health policies and preventive strategies in the popula- 
tion. 
In this paper we describe baseline characteristics of 
enrolled subjects. 
2. MATERIAL AND METHODS 
The study was conducted in accordance to the Declara- 
tion of Helsinki, Guidelines for Good Clinical practice, 
and the Italian bioethics regulations and laws. The study 
was approved by the local Ethic Committee and all sub- 
jects gave written informed consent to the study (proto- 
col code SEFAP/Pr. 0003). 
2.1. Study Design 
The Italian Society of General Medicine (SIMG) identi- 
fied 54 general practitioners (coordinators) that were 
active at local level and distributed throughout the Ital- 
ian territory (both rural and urban areas) in proportion 
to the regional population density. Each coordinator had 
to contact other general practitioners (GPs) who were 
operating on the same territory, to reach a group of 14 
GPs. 
Overall, 764 GPs were invited to participate to the 
study as investigators. They had to meet all the following 
pre-requisites:  
 age: <52 years; 
 practice size: >1000 subjects; 
 computerised patient records system; 
 access to the web. 
The GPs who adhered to the proposal had to registered 
in the project website and to provide some personal in- 
formation and their patients number. Each investigator 
was required to enrol 16 subjects aged 40 to 79 years, 
randomly selected among his patients, following a ran- 
dom number list generated by the coordinating Centre in 
Milan based on self-reported number of patients. The 
patient selection procedure was subject to random con- 
trol by the local coordinators. Subjects who didn’t give 
their consensus or who were not eligible for practical 
reasons (e.g. subjects with walking disabilities, severe 
handicap, or suffering from an invaliding disease or a 
severe mental illness) were excluded from the random-
ized sample. The subjects’ enrolment started in March 
2002 and ended in June 2005. 
2.2. Data Collection  
Subjects’ clinical history and clinical information were 
collected during a standardised visit performed by the 
investigating physician.  
Information about smoking habit, physical activity, 
alcohol use and chronic drug treatments were collected 
directly from the patient during the same examination. 
Smoking habit was classified as current (patient smoking 
at least one cigarette per day) or former (at least one year 
from smoking cessation). Self-reported leisure-time phy- 
sical activity was classified as present or non-present. 
The use of alcohol was evaluated by adding the con- 
sumption of red and/or white wine, beer and liquors. In- 
formation on chronic therapies was also collected. 
Weight and height measures, obtained from lightly 
clothed patients, were expressed in terms of body mass 
index (BMI, weight in kilos divided by the square value 
of height, in meters).  
The measurement of blood pressure (BP) was per- 
formed with the patient in sitting position, after 4 minute 
of rest, applying the appropriate cuff on the right arm. 
Systolic and diastolic blood pressure was identified at the 
beginning of the first and the fifth phase of the Korotkoff 
sounds, using a mercury sphygmomanometer with the 
appropriate cuff. Three consecutive readings were re- 
corded and their mean was considered for the analysis. 
Heart rate was assessed as beats per minute after the last 
measurement of BP.  
The presence of angina pectoris or of a history of 
myocardial infarction, coronary artery bypass graft or 
coronary angioplasty, stroke, transient ischemic attacks, 
claudicatio and left ventricular hypertrophy were as- 
sessed by retrieving the medical records of the subject 
and by direct inquiry. Subjects with a history of cardio- 
vascular events (excluding left ventricular hypertrophy) 
were considered in secondary prevention. 
Family history for premature cardiovascular diseases 
was determined when episodes of stroke and/or myocar- 
dial infarction were reported for one or more first-degree 
relatives, <55 years old for men and <65 years old for 
women. Family history for hypertension, dislipidemia, 
and diabetes was also evaluated. 
All relevant subject records were entered in a comput- 
erized patient chart directly by the investigating physi- 
cian and then sent to a central server via web. 
Blood samples were drawn at the beginning of the en- 
rolment visit. Blood was obtained between 8 to 10 am, 
from the antecubital vein, in sitting position, after 12 
hours of fasting and alcohol abstinence. Blood samples 
were then collected in EDTA or monoiodine-acetate 
(only for glucose assessment) coated tubes and shipped 
by courier at 4˚C temperature to the central laboratory 
(Fleming SpA, in Brescia, Italy) within 24 hours, where 
the biochemical parameters were determined. The bio- 
chemical evaluation was performed following the criteria 
of the World Health Organization Lipid Reference La- 
boratories.  
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Upon arrival, the samples were centrifuged to obtain 
the plasma. Levels of total cholesterol (TC), glucose and 
triglycerides (TG) were measured by a chromatometric 
enzymatic method; the plasma levels of apolipoprotein B 
by a latex enhanced turbidimetric immuno-assay. Plasma 
HDL cholesterol levels (HDL-C) were measured after 
the precipitation of the apolipoprotein B containing lipo- 
proteins with dextran-magnesium-chloride. All determi- 
nations were performed by an automatic analyzer (AD- 
VIA 1650; Bayer, Germany). Fibrinogen plasma levels 
(1.8 - 3.5 g/L) were assessed by a turbidimetric method 
with Nefelometro BNA 100 (Boehring, Italia). The low 
density lipoprotein cholesterol (LDL-C) values were 
calculated using the Friedewald formula (TC minus 
HDL-C minus 1/5 TG). 
Serum 1 mL aliquots (4 - 5 for each sample) were fro- 
zen at −80˚C for further biochemical evaluation. White 
cells were frozen at −20˚C for polymorphism search/ 
genetic research. 
Criteria used for specific diagnosis were: 
 Hypercholesterolemia: plasma levels of TC ≥ 200 
mg/dL or LDL-C ≥130 mg/dL or pharmacological 
treatment with statins and/or simvastatin + ezetimibe. 
 Hypertriglyceridemia: plasma levels of TG ≥ 170 mg/ 
dL or pharmacological treatment with fibrates and/or 
omega-3.  
 Mixed dyslipidemia: hypercholesterolemia and hy- 
pertriglyceridemia, as defined above. 
 Hypertension: recorded diagnosis by physician or 
systolic BP ≥ 140 mm Hg or diastolic BP ≥ 90 mm 
Hg or currently taking medication to lower high BP 
(NHANES criteria [6]). 
 Type 2 diabetes mellitus: recorded diagnosis by phy- 
sician or fasting blood glucose levels ≥ 126 mg/dL or 
currently taking antidiabetic drugs (oral hypoglycae- 
mic medication and/or insulin). 
 Overweight: body mass index (BMI) ≥ 25 and <30 
kg/m2; 
 Obesity: BMI ≥ 30 kg/m2; 
 Metabolic Syndrome (MetS): presence of at least 3 
of 5 of the listed characteristics [7]: abdominal obe- 
sity, given as waist circumference, men > 102 cm, 
women > 88 cm; triglycerides ≥ 150 mg/dL; HDL 
cholesterol, men < 40 mg/dL, women < 50 mg/dL; 
blood pressure ≥ 130/85 mmHg; fasting glucose ≥ 
110 mg/dL. BMI was used as a surrogate of waist cir- 
cumference, men ≥ 28 kg/m2, women ≥ 25 kg/m2 
(approach validated in a subgroup of about 1000 sub- 
jects: assignment to MetS/noMetS consistent in 92% 
of cases in males and 97% in females).  
The coronary heart disease risk (CHD risk % in 10 
years) was calculated using the Framingham algorithm 
[8], as recommended at the time of the study by the Ital- 
ian regulatory Agency (AIFA) for the prescription of 
statin drugs [9]; the global cardiovascular risk (CVD risk 
% in 10 years) was evaluated using the CUORE algo- 
rithm [10], developed from epidemiological data ob- 
tained in Italy, as reported by Italian recommendations 
since 2003 [11]. Based on Framingham or CUORE 
scores, subjects were stratified in four risk classes (<5% 
low-risk; 5% - 10% mild-risk; 10% - 20% moderate- 
risk; ≥20% high risk).  
2.3. Statistical Analysis 
Normally distributed variables are presented as mean 
values [±standard deviation, SD] and not normally dis- 
tribute variables as median [interquartile range, IQR], 
while qualitative variables are presented as frequencies. 
Comparisons between continuous variables across sex 
groups were performed by using the t-test for independ- 
ent sample. Comparisons between proportions across sex 
groups for categorical (and qualitative) variables were 
performed by using non-parametric tests. All reported 
p-values are based on two-sided tests and compared to a 
significance level of 5%. 
All statistical analyses were performed using the Win- 
dows 16.0 version of SPSS (SPSS, Inc., Chicago, Illinois). 
3. RESULTS 
432 GPs participated to the CHECK study (mean age 
47.8 years, 80.1% male; 56.5% participation rate). Each 
of them enrolled up to 16 subjects, following the ran- 
domised sampling procedure. Overall, 6890 subjects 
were enrolled; 1044 (15.1%) of them did not attend the 
medical visit and were excluded from the study sample; 
the blood samples of 131 subjects (1.9%) were not proc- 
essable, although their anamnestic data were included in 
the analysis.  
5846 subjects were included in the final analysis (Fig- 
ure 1). Men were 49.7% of the cohort. The mean age was 
57.8 years (58.2 years for men and 57.4 for women). 
Comparison between the Check demographics and the 
latest available census data [12] showed small difference: 
women were slightly under-represented in the CHECK 
sample (50.3% vs. 52.6% respectively); the 50 - 59 and 
60 - 69 age groups, conversely, were slightly over-rep- 
resented (30.5% vs. 27.0% and 28.0% vs. 24.6%, respec- 
tively). 
The main outcomes of the study are shown in Tables 
1-4. The average level of education is quite low: 33.0% 
of subjects achieved only primary education, but this 
percentage was higher in women (36.7% vs. 29.2%). 
32.9% reported to be retired, with a high proportion of 
men (65.8%); 23.3% were housewives (45.8% of the 
female sample). Smoke habit and alcohol consumption 
were more prevalent in men (24.3% vs. 18.6% and 
62.4% vs. 28.4%, respectively), whereas physical inac-  
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Figure 1. Flow chart of the study. 
 
tivity was more present in women (84.1% vs. 75.0%) 
(Table 1). 
Mean BMI (±SD) was 26.5 ± 4.3 kg/m2, putting the 
sample in the overweight range; this was observed in 
both genders. Mean SBP/DPB values were (132.0 ± 
14.7)/(81.2 ± 7.9) mm Hg, slightly higher than cut off for 
pre-hypertension. Mean total cholesterol was 205.3 ± 
35.9 mg/dL, while LDL-cholesterol was 124.9 ± 29.9 
mg/dL, the former just higher and the latter slightly 
lower than desirable levels, due to HDL-cholesterol val- 
ues (54.8 ± 12.2 mg/dL) (Table 2).  
As shown in Table 3, 51.8% of subjects were hyper- 
tensive, 13.0% were diabetic, and 55.6%/20.8% were hy- 
percholesterolemic/hypertriglyceridemic. 8.6% had a his- 
tory of cardiovascular events and thus could be defined 
as in secondary CV prevention. The 65.0% of the remain- 
ing subjects had a global CV risk in 10 years (calculated 
with CUORE algorithm) lower than 5%, with a remark- 
able difference between genders (mean values: 7.8% ± 
7.1% in men vs. 2.8% ± 3.1% in women) (Table 4). 
4. DISCUSSION 
The main objective of the CHECK study was to evaluate 
the cross-sectional prevalence of CVD and cardiovascu- 
lar risk factors in a cohort of randomly selected Italian 
subjects, aged 40 to 79 years. 
The CHECK sample proved to be representative of the 
Italian population in the same age range. The differences 
observed by comparing the Check demographics to the 
latest available census data [12] are small, and of limited 
relevance. This was probably due to a larger participation 
to the study of subjects in a non-working age or condition.  
The CHECK study provided a detailed and in depth 
description of the prevalence of cardiovascular risk fac- 
tors and the main cardiovascular pathologies in the Ital- 
ian population. In order to put our findings into a wider 
context, we compare them with other national surveys, 
while maintaining a worldwide perspective. 
Smoking is estimated to cause nearly 10% of cardio- 
vascular disease (5.4 millions of deaths) [13]. Currently, 
there are about 1 billion smokers worldwide [14]. The 
proportion of smoking subjects in the CHECK sample 
was 21.4% (men 24.3% and women 18.6%). These fig- 
ures were slightly lower than the official census data 
(24.5% in 2003, 22.6% in 2004) [15]; the Check cohort 
excluded the 25 - 34 age group, the one with the highest 
prevalence of smokers (31.4%), especially among men. 
The reduced prevalence of smokers in the CHECK co- 
hort, as compared to previous epidemiological data [16], 
could also reflect the declining smoking habits in the 
Italian population, as a result of educational programs 
and smoking restrictions enforced in public buildings.  
Physical inactivity is one of the leading risk factors for 
mortality and is estimated to cause about 30% of ischae- 
mic heart disease burden [13]. Globally, around 31% of 
adults are insufficiently active (men 28% and women 
34%) [17]. Concerning leisure-time physical activity, the 
self-reported information obtained from the CHECK 
cohort were less favourable than the data derived from 
other studies. The prevalence of physical inactivity was 
75% in men and 84% in women, vs. 34% in men and 
46% in women observed, as an example, in the Atlante 
study [18].  
Overweight and obesity lead to adverse metabolic ef- 
fects on blood pressure, cholesterol, triglycerides and 
insulin resistance [13]; all over the world, 2.8 million 
people die each year as a result of being overweight [13]. 
A total of more than half a billion adults worldwide are 
obese [19]. The mean BMI of the CHECK cohort was 
26.5 kg/m2, well within the overweight range. 17.4% of 
the cohort subjects were obese, with a higher prevalence 
in women than in men (18.8% vs. 16.0%, respectively). 
In the PASSI study, a national survey (self-reported in- 
formation) conducted on younger people aged 18 - 69 
years [20], 32% of Italians are overweight, while one in 
ten is obese [21]. 
Raised blood pressure is the leading risk factor for 
cardiovascular disease mortality, causing more than 7 
million deaths every year worldwide. Globally, preva- 
lence of hypertension in adults is around 40% [13]. In 
our study, the mean blood pressure value was 132.0/81.2 
mmHg. Hypertension was present in more than half of 
the sample, with a higher prevalence in men (54.1% M 
vs. 49.5% W). The CHECK mean SBP values were com- 
parable to those obtained in other Italian observational 
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Table 1. Sociodemographic and lifestyle characteristics in total and sex-stratified sample. 
 Total sample Men Women 
Subjects, n (%) 5846 2903 (49.7) 2943 (50.3) 
Age, mean ± SD (*) 57.8 ± 10.3 58.2 ± 10.1 57.4 ± 10.5 
Age distribution, N (%)§ 
40 - 49 years 1517 (26.0) 689 (23.7) 828 (28.1) 
50 - 59 years 1784 (30.5) 912 (31.4) 872 (39.6) 
60 - 69 years 1638 (28.0) 844 (29.1) 794 (27.0) 
70 - 79 years 907 (15.5) 458 (15.8) 449 (15.3) 
Occupational status, N (%)§ 
Employed 2109 (36.5) 1360 (47.4) 749 (25.8) 
Housewife 1347 (23.3) 14 (0.5) 1333 (45.8) 
Retiree 1902 (32.9) 1252 (43.7) 650 (22.3) 
Unemployed 51 (0.9) 33 (1.2) 18 (0.6) 
Other 367 (6.4) 207 (7.2) 160 (5.5) 
Educational level (highest degree), N (%)§ 
None 98 (1.7) 37 (1.3) 61 (2.1) 
Elementary 1905 (33.0) 836 (29.2) 1069 (36.7) 
Junior high 1840 (31.9) 916 (32.0) 924 (31.8) 
High school 1488 (25.8) 808 (28.2) 680 (23.4) 
University 445 (7.7) 269 (9.4) 176 (6.0) 
Life habits, N (%)§ 
Smokers 1253 (21.4) 706 (24.3) 547 (18.6) 
Regular exercise 1181 (20.4) 717 (25.0) 464 (15.9) 
Alcohol users 2613 (45.2) 1788 (62.4) 825 (28.4) 
*Men vs. women (t-test) p = 0.003; §Men vs. women (non-parametric tests) p < 0.05. 
 
Table 2. Anthropometric, vital and biochemical parameters in total and sex-stratified sample, mean ± SD. 
 Total sample Men Women* 
Height (m)  N = 5843 1.65 ± 0.09 1.71 ± 0.07 1.60 ± 0.07 
Weight (kg)  N = 5835 72.5 ± 13.4 78.5 ± 11.7 66.6 ± 12.4 
BMI (Kg/m2)  N = 5835 26.5 ± 4.3 26.9 ± 3.5 26.2 ± 4.9 
SBP (mmHg) N = 5844 132.0 ± 14.7 133.0 ± 13.8 130.9 ± 15.5 
DBP (mmHg) N = 5844 81.2 ± 7.9 81.9 ± 7.8 80.6 ± 8.0 
Heart rate (bpm)  N = 5773 73.3 ± 8.5 72.6 ± 8.5 74.0 ± 8.5 
TC (mg/dL)  N = 5710 205.3 ± 35.9 202.5 ± 35.7 208.0 ± 35.9 
HDL-C (mg/dL)  N = 5710 54.8 ± 12.2 50.7 ± 10.4 58.8 ± 12.4 
TG (mg/dL)  N = 5710 132.8 ± 102.1 149.9 ± 120.6 115.9 ± 76.1 
median [IQR]  109 [78 - 157] 119 [86 - 177] 98 [72 - 140] 
LDL-C (mg/dL)§ N = 5614 124.9 ± 29.9 123.3 ± 29.3 126.5 ± 30.3 
ApoB (mg/dL)  N = 5710 111.4 ± 25.2 112.5 ± 25.3 110.4 ± 25.1 
Non-HDL-C (mg/dL)# N = 5710 150.5 ± 33.8 151.8 ± 33.6 149.2 ± 34.0 
Glucose (mg/dL)  N = 5547 98.3 ± 28.2 101.7 ± 29.6 94.9 ± 26.3 
median [IQR]  92 [84 - 102] 95 [87 - 106] 89 [83 - 98] 
Fibrinogen (g/L)  N = 5710 3.41 ± 0.69 3.34 ± 0.70 3.47 ± 0.68 
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglycerides; apoB: apolipoprotein B; *Men vs 
women (t-test) p < 0.01 for all comparisons; §Obtained by the Friedewald formula; #(TC) – (HDL-C). 
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Table 3. Prevalence of cardiovascular disease and related comorbidities in total and sex-stratified sample, N (%). 
 Total sample Men Women p* 
Comorbidities 
Hypertension° N = 5774 2990 (51.8) 1549 (54.2) 1441 (49.5) <0.001 
Hypercholesterolemia° N = 5707 3172 (55.6) 1514 (53.5) 1661 (57.9) <0.001 
Hypertriglyceridemia° N = 5707 1191 (20.8) 780 (27.8) 411 (14.5) <0.001 
Mixed dyslipidemia° N = 5707 935 (14.8) 598 (21.3) 337 (11.9) <0.001 
DM2° N = 5568 723 (13.0) 432 (15.6) 291 (10.4) <0.001 
Obesity° N = 5853 1011 (17.3) 463 (16.0) 552 (18.8) <0.01 
Metabolic syndrome° N = 5660 1306 (23.1) 629 (22.3) 677 (23.8) NS 
Cardiovascular events 
Stable angina N = 5846 113 (1.9) 68 (2.3) 45 (1.5) <0.05 
Unstable angina N = 5846 74 (1.3) 48 (1.7) 26 (0.9) <0.05 
Myocardial infarction  N = 5846 180 (3.1) 154 (5.3) 26 (0.9) <0.001 
CABG N = 5846 46 (0.8) 39 (1.3) 7 (0.2) <0.001 
PTCA N = 5846 76 (1.3) 65 (2.2) 11 (0.4) <0.001 
Transient ischemic attack  N = 5846 118 (2.0) 71 (2.4) 47 (1.6) <0.05 
Ischemic stroke N = 5846 41 (0.7) 25 (0.9) 16 (0.5) NS 
Claudicatio N = 5846 82 (1.4) 73 (2.5) 9 (0.3) <0.001 
Secondary prevention^ N = 5846 501 (8.6) 354 (12.2) 147 (5.0) <0.001 
LVH N = 5846 526 (9.0) 288 (9.9) 238 (8.1) <0.05 
Family history 
Coronary heart disease N = 5846 681 (11.6) 323 (11.1) 358 (12.2) NS 
Cerebrovascular disease N = 5846 454 (7.8) 205 (7.1) 249 (8.5) NS 
Dyslipidemia N = 5846 1579 (27.0) 763 (26.3) 816 (27.7) <0.001 
Hypertension N = 5846 2897 (49.6) 1346 (46.4) 1551 (52.7) <0.001 
DM2 N = 5846 1542 (26.4) 740 (25.5) 802 (27.3) NS 
DM2: type 2 diabetes mellitus; CABG: coronary artery bypass graft surgery; PTCA: percutaneous transluminal coronary angioplasty; LHV: left ventricular hypertrophy; 
NS: not significant; °Criteria used for specific diagnosis are described in Methods paragraph; ^Criteria for definition are described in Methods paragraph; *Men vs. women 
(non-parametric tests). 
 
Table 4. CHD-risk classes and CVD-risk classes in total and sex stratified sample. 
Framingham CUORE 
 
Total sample Men Women Total sample Men Women 
Risk %, mean ± SD°* 10.1 ± 8.3 13.5 ± 8.9 7.0 ± 6.3 5.2 ± 5.9 7.8 ± 7.1 2.8 ± 3.1 
Risk classes, n (%)§ 
<5.0% 1415 (30.8) 299 (13.6) 1116 (46.6) 2736 (65.0) 916 (45.4) 1820 (83.2) 
5.0% - 9.9% 1420 (30.9) 627 (28.4) 793 (33.1) 858 (20.4) 566 (28.0) 292 (13.4) 
10.0% - 19.9% 1257 (27.3) 884 (40.1) 373 (15.6) 470 (11.2) 403 (20.0) 67 (3.1) 
>=20.0% 505 (11.0) 394 (17.9) 111 (4.6) 142 (3.4) 126 (6.6) 8 (0.4) 
°Values calculated within the limits of each algorithm; *Men vs. women (t-test) p < 0.001; §Men vs. women (non-parametric tests) p < 0.001.   
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studies, while the DBP values resulted slightly lower (82 - 
86 mmHg) [18]. Compared to the population sample 
observed in the Atlante study, the CHECK cohort show- 
ed a higher overall incidence of hypertensive subjects 
(52% M vs. 45% W), possibly due to a higher prevalence 
of older subjects in the CHECK sample. 
Raised total cholesterol is a major cause of disease 
burden as a risk factor for ischaemic heart disease and 
stroke. Overall, it is estimated to cause 2.6 million deaths 
(4.5% of total). The global prevalence of hypercholes- 
terolemia among adults is about 39% [13]. The mean 
plasma total cholesterol levels in the CHECK cohort 
were 205.3 mg/dL. The prevalence of hypercholes- 
terolemia was 55.6%. Hypertriglyceridemia and mixed 
dyslipidemia were identified in 20.8% and 14.8% of the 
enrolled subjects, respectively. Lipid data observed in the 
CHECK and in the Atlante study showed relevant simi- 
larities: in both cohorts, women showed a higher level of 
TC, LDL-C, and HDL-C than the same level reported for 
men, but lower TG values. TC mean values observed in 
the CUORE population [22], on the other hand, were sig- 
nificantly higher than those found in CHECK (CUORE 
225.4 mg/dL M and 229.0 mg/dL W vs. CHECK 202.5 
mg/dL M and 208.0 mg/dL W). This difference is con- 
sistent with the trend of progressive reduction of blood 
TC levels observed over the last decades in Italy. 
Impaired glucose tolerance and impaired fasting gly- 
caemia are risk categories for future development of 
diabetes and cardiovascular disease [23]. A 2004 survey 
showed that more than 3 million people died from con- 
sequences of high blood sugar [24]. The global preva- 
lence of diabetes is estimated to be 10% [13]. In the 
CHECK cohort, the mean level of fasting glucose was 
98.3 mg/dL (101.7 M vs. 94.9 W). Based on GPs diag- 
nosis and/or presence of anti-diabetes therapies and/or 
plasma glucose levels ≥ 126 mg/dL, type II diabetes 
prevalence was 13.0%. This prevalence was higher than 
that observed in the Health Search GP’s database of Ital- 
ian general practice [25] for similar age (10% - 11%; 
unpublished observation). This difference can be par- 
tially explained by different diagnostic criteria (based on 
at least two assessments in clinical practice compared to 
the single time determination in the CHECK study pro- 
tocol), or by the identification of previously unknown 
cases in the CHECK sample, due to the generalised 
screening. In the Atlante cohort, the mean fasting glu- 
cose levels was lower (93 mg/dL M vs. 87 mg/dL W), 
leading to a lower prevalence of type II diabetes (Atlante 
9% M and 6% W vs. CHECK 15.6% M and 10.4% W). 
This difference could be partially explained by the dif- 
ferent timeframe of the two studies (Atlante from 1998 
vs. CHECK from 2001): over the last years, a general- 
ised increase in the prevalence of type II diabetes in 
Western populations has been observed. Moreover, in the 
Atlante study the blood glucose level was estimated from 
a sample of capillary blood, where glucose concentra- 
tions are on average significantly lower than in plasma. 
Cardiovascular disease is the number one cause of 
death globally. In Italy, an estimated almost 240,000 
people died from CVDs in 2008, representing 41% of all 
total deaths [26]. A clinical history of previous cardio- 
vascular events was observed in 8.6% of the individuals 
included in the CHECK sample. The prevalence of such 
diagnosis was twice as high in men than in women. The 
prevalence of a clinical history of myocardial infarction 
was higher in the CHECK than in the Atlante study, es- 
pecially in men (CHECK 5.3% M and 0.9% W vs. At- 
lante 1.5% M and 0.4% W). The difference could be ex- 
plained by the different methodological approach (in- 
formation collected in a GP interview vs. hospital valida- 
tion) and age differences. 
The risk of future fatal and non-fatal cardiovascular 
events was assessed using two different algorithms, 
based on the outcomes of the Framingham and the Cuore 
cohorts. The mean coronary risk at 10 years, calculated 
with the Framingham algorithm, was 10.1%, while the 
cardiovascular risk calculated with the CUORE algo- 
rithm showed an average value of 5.2%. This difference 
was expected, since the Framingham algorithm is known 
to over-estimate the coronary risk of the Italian popula- 
tion [27]. Compared to the CUORE population data [28], 
the mean cardiovascular risk for the CHECK cohort was 
slightly lower (CUORE 7.8% M and 2.8% W vs. CHECK 
8.7% M and 3.3% W). 
The innovative design of the CHECK study responded 
to the emerging need of determining the prevalence of 
cardiovascular risk factors directly from primary care, 
following a rigorous and unbiased research methodology. 
The randomisation of the sample, the web-based data 
collection of primary data, the territorial quality control 
operated by local coordinators, and the centralised labo- 
ratory procedures increase the external validity of the 
study, conferring a general significance to the epidemi- 
ological outcomes.  
A follow-up of the cardiovascular events (fatal and 
nonfatal) occurred to all enrolled subjects is currently 
ongoing. It will provide the opportunity to evaluate the 
underlying prevalence of factors predisposing the onset 
of cardiovascular disease. Moreover, frozen samples 
provide the possibility of further biochemical evaluations, 
as the characterization of specific population subgroups 
through polymorphism search/genetic research.  
The assessment of the gap between risk factor levels 
and recommended targets will provide evidence to aid 
clinical decision making about tailored non pharmacol- 
ogical and pharmacological interventions and to achieve 
optimal resources allocation. 
The CHECK study has some methodological limita- 
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tions, previously described. Importantly, the prevalence 
of cardiovascular events could have been underestimated, 
as the participating general practitioners reported those 
events at best of their knowledge, simply transcribing the 
diagnose related groups (DRG) codification of the events 
as reported by the hospital discharge letter, without any 
form of control on the appropriateness of the diagnoses. 
In addition, the peculiar design of the study, with pro- 
gressive steps of GPs involvement, determined a partici- 
pation rate lower than expected. The fact that local in- 
vestigators did not participate in the enrolment meetings 
with the coordinating Centre, but were trained by their 
coordinators, may have weakened their motivation. How- 
ever, no significant differences have been found between 
actively participating GPs and those who did not com-
plete the preliminary steps. 
5. CONCLUSIONS 
The CHECK study confirmed the significant burden 
caused by the cardiovascular disease to the health care 
system and to society. In the randomised cohort observed, 
1 out of 2 subjects was suffering from high blood pres- 
sure or high cholesterol, 1 out of 5 was obese and 1 out 
of 10 was a type 2 diabetic. The elevated prevalence of 
lifestyle risk factors observed in the Italian population 
raises the issue of moral hazard: the limited willingness 
of subjects covered by the National Healthcare System to 
take action and modify behavioural risks, in favour of 
deferring the issue to pharmacological prevention or 
treatment of the cardiovascular events at a later stage. 
While this normative issue is well known in economics 
of public health, the CHECK findings on the prevalence 
and co-occurrence of key behavioural and clinical risk 
factors is an emerging concern and it demands further 
research. Despite the fact that most subjects included in 
the study had been followed-up by general practitioners 
for years, the vast majority of them still showed the 
presence of one or more risk factors. 
The high proportion of subjects with multiple risk fac- 
tors in combination with the elevated prevalence of car- 
diovascular disease projects a shadow on the effective- 
ness of current cardiovascular prevention policies in pri- 
mary care. The epidemiological outcomes of this study 
could be used as a baseline to set priorities and objectives 
for future intervention, as well as a benchmark, against 
which the effectiveness of the implementation of future 
prevention policies in primary care should be measured. 
The further development of the CHECK study is aimed to 
facilitate the recognition and to improve the management 
of cardiovascular diseases in the Italian general practice. 
6. ACKNOWLEDGEMENTS 
The CHECK study was supported in part by an unconditioned educa- 
tional grant from AstraZeneca SpA. Thanks to Maria Grazia Lanfranco 
and Elena Loggia for their assistance in completing our survey. 
 
REFERENCES 
[1] Alwan, A., Maclean, D.R., Riley L.M., et al. (2010) 
Monitoring and surveillance of chronic non-communi- 
cable diseases: Progress and capacity in high-burden 
countries. Lancet, 376, 1861-1868.  
doi:10.1016/S0140-6736(10)61853-3 
[2] Fuster, V. and Kelly, B.B. (2010) Promoting Cardiovas-
cular Health in the Developing World: A Critical Chal-
lenge to Achieve Global Health. Committee on Prevent-
ing the Global Epidemic of Cardiovascular Disease: 
Meeting the Challenges in Developing Countries. Insti-
tute of Medicine. National Academies Press, Washington. 
[3] ERA (2009) Epidemiologia e Ricerca Applicata. 
http://www.atlantesanitario.it/index.php?option=com_con
tent&view=article&id=82&Itemid=93  
[4] ISTAT (2012) GeoDEMO. 
http://demo.istat.it/unitav/index.html?lingua=ita  
[5] AIFA (2012) Rapporti OsMed—L’uso dei farmaci in 
Italia. 
http://www.agenziafarmaco.gov.it/it/content/rapporti-osm
ed-luso-dei-farmaci-italia  
[6] CDC (2011) National Health and Nutrition Examination 
Survey. http://www.cdc.gov/nchs/nhanes.htm  
[7] Adult Treatment Panel III (2001) Executive Summary of 
the Third Report of the National Cholesterol Education 
Program (NCEP) Expert Panel on Detection, Evaluation, 
and Treatment of High Blood Cholesterol in Adults. 
Journal of the American Medical Association, 285, 2486- 
2497. doi:10.1001/jama.285.19.2486 
[8] Anderson, K.M., Wilson, P.W., Odell, P.M. and Kannel, 
W.B. (1991) An updated coronary risk profile. A state- 
ment for health professionals. Circulation, 83, 356-362.  
doi:10.1161/01.CIR.83.1.356 
[9] AIFA (2012) Le nuove note CUF. BIF 5-6/2000. 
http://www.agenziafarmaco.gov.it/it/content/bif-5-62000  
[10] Palmieri, L., Panico, S., Vanuzzo, D., et al. (2004) 
Evaluation of the global cardiovascular absolute risk: The 
Progetto CUORE individual score. Ann Ist Super Sanita, 
40, 393-399. 
[11] AIFA (2012) Le note. BIF 2/2004. 
http://www.agenziafarmaco.gov.it/it/content/bif-22004  
[12] ISTAT (2012) 14 censimento generale della popolazione 
e delle abitazioni. http://dawinci.istat.it/MD/  
[13] WHO (2009) Global health risks mortality and burden of 
disease attributable to selected major risks. World Health 
Organization, Geneva. 
[14] WHO (2012) Tobacco. 
http://www.who.int/mediacentre/factsheets/fs339/en/inde
x.html  
[15] ISTAT (2012) Condizioni di salute e ricorso ai servizi 
sanitari: I fumatori in Italia. 
http://www3.istat.it/salastampa/comunicati/non_calendari
o/20060110_00/  
Copyright © 2012 SciRes.                                                                       OPEN ACCESS 
E. Tragni et al. / Open Journal of Epidemiology 2 (2012) 90-100 
Copyright © 2012 SciRes.                                                                      
98 
 OPEN ACCESS 
[16] Zuccaro, P., Pacifici, R., Giampaoli, S., et al. (2001) 
Fumo: Il contesto epidemiologico nazionale. Ital Heart 
Journal, 2, 13-18. 
[17] WHO (2012) Physical inactivity: A global public health 
problem. 
http://www.who.int/dietphysicalactivity/factsheet_inactiv
ity/en/  
[18] OEC (2004) Atlante italiano delle malattie cardiovas- 
colari—Second edition. Ital Heart Journal, 5, 1S-101S. 
[19] Finucane, M.M., Stevens, G.A., Cowan, M.J., et al. 
(2011) National, regional, and global trends in body-mass 
index since 1980: Systematic analysis of health examina- 
tion surveys and epidemiological studies with 960 coun- 
try-years and 9.1 million participants. Lancet, 377, 557- 
567. doi:10.1016/S0140-6736(10)62037-5 
[20] Baldissera, S., Campostrini, S., Binkin, N., et al. (2011) 
Features and initial assessment of the Italian Behavioral 
Risk Factor Surveillance System (PASSI), 2007-2008. 
Preventing Chronic Disease, 8, A24. 
[21] Trinito, M., Bertozzi, N., Bietta, C., et al., (2006) Analisi 
di alcuni fattori di rischio cardiovascolari nella popo- 
lazione delle ASL partecipanti allo studio PASSI. Noti- 
ziario dell’Istituto Superiore di Sanità, 19, iii-iv. 
[22] ISS (2012) Il Progetto CUORE: Assetto lipidico. 
http://www.cuore.iss.it/fattori/colesterolemia.asp  
[23] Levitan, E.B., Song, Y., Ford, E.S. and Liu, S. (2004) Is 
nondiabetic hyperglycemia a risk factor for cardiovascu- 
lar disease? A meta-analysis of prospective studies. Ar- 
chives of Internal Medicine, 164, 2147-2155.  
doi:10.1001/archinte.164.19.2147 
[24] WHO (2012) Diabetes. 
http://www.who.int/mediacentre/factsheets/fs312/en/  
[25] Filippi, A., Vanuzzo, D. Bignamini, A.A., Sessa, E. 
Brignoli, O. and Mazzaglia, G. (2005) Computerized ge- 
neral practice databases provide quick and cost-effective 
information on the prevalence of angina pectoris. Ital 
Heart Journal, 6, 49-51. 
[26] WHO (2011) Noncommunicable diseases country pro-
files. World Health Organization, Geneva. 
[27] Menotti, A., Puddu, P.E. and Lanti, M. (2000) Compari- 
son of the Framingham risk function-based coronary 
chart with risk function from an Italian population study. 
European Heart Journal, 21, 365-370.  
doi:10.1053/euhj.1999.1864 
[28] ISS (2012) Il Progetto CUORE: Rischio cardiovascolare 
globale assoluto. 
http://www.cuore.iss.it/fattori/RischioGlobaleAssoluto.asp  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E. Tragni et al. / Open Journal of Epidemiology 2 (2012) 90-100 99
Appendix 
Participating Investigators in the CHECK Study Group (Bold Type for Coordinators) 
 
Aalders Maria Anna 
Abbate Giuseppe 
Agati Riccardo 
Alano Raffaele 
Alba Mauro 
Alemagna Silvia 
Alunni Massimo 
Alvaro Antonio 
Amato Fabio 
Ammendola Erminia 
Amodeo Vincenzo 
Amoretti Giovanni 
Andrani Alberto 
Antiga Ivo 
Appolonia Giorgio 
Aramini Enrico 
Arisi Marco Emilio 
Artebani Adriano 
Atzei Massimiliano 
Azzolini Micheline 
Bachetti Francesco 
Bagagli Franco 
Baldicchi Lorella 
Banzi Roberta 
Barba Ettore Maria 
Barbato Pasquale Claudio 
Barral Gino 
Battaggia Alessandro 
Battigelli Doriano 
Baudi Marina 
Bellumori Giovanni 
Beltrami Giuseppe 
Benincasa Anna Maria 
Berardi Mario 
Berlengiero Claudio 
Bernardelli Stefano 
Bernardi Giuseppe 
Bertelle Evandro 
Bettini Gianluca 
Bevacqua Giuseppe 
Bevilacqua Stefano 
Bianconi Giuseppe 
Biggioggero Giovanni 
Bini Vincenzo 
Bocchino Giancarlo 
Boccone Nicolfranco 
Boito Giancarlo 
Bollo Alberto Maria 
Boncompagni Salvatore 
Bond Giuseppe 
Bonesi Maria Grazia 
Bono Gianfranco 
Boscaro Federica 
Bossi Paolo 
Bozza Giulio 
Bracone Enrico 
Brandodoro Lucio 
Brasesco Pierclaudio 
Breviario Adele 
Brizzi Antonio 
Brugnetta Maurizio 
Bruno Giuseppe 
Buemi Giuseppe 
Bufano Carmine 
Bugli Tiziano 
Burigo Daniela 
Buzzatti Agostino 
Caccamo Orazio Antonio 
Cadamosti Danilo 
Cagliesi Francesco 
Caleffa Manuela 
Cammisa Nicolo’ 
Campo Franceso 
Campobello Margherita 
Caputo Stanislao 
Caraccio Nicola 
Cardi Silvio 
Cardinale Fulvio 
Caregnato Massimo 
Cariola Gianni 
Carlino Saverio 
Carminati Luisa Angela 
Carnelli Feliciano 
Carnesalli Franco 
Caruso Ciro 
Casale Ezio 
Casini Marcella 
Cassanelli Marco 
Castiello Maria Luisa 
Castriotta Antonio 
Catalano Domenico   
Cataldi Maria Elvira 
Ceccarini Agostino 
Celebrano Mario 
Celora Amedeo 
Cerracchio Alessandro 
Cesaro Andrea 
Cesaro Federico 
Chiriatti Alberto 
Cipriani Rosa 
Collura Giuseppe 
Colombo Valter 
Coluccia Salvatore 
Conte Sergio 
Corda Andrea 
Costa Roberto 
Cottani Antonio 
Crivellenti Giuseppe 
D’Ambrosio Gaetano  
D’Angelo Massimo 
Dalla Rosa Rosanna 
Damico Giansanto 
De Andreis Bessone Pier Luigi 
De Benedictis Antonio 
De Conto Umberto 
De Mola Cosimo 
De Rosa Antonio 
De Tommasi Roberto 
Del Nero Barbara 
Della Briotta Ivana 
Dell’Orco Mario Domenico 
Dell’Orco Mario Lucio 
Di Candia Giuseppe 
Di Carlo Vittorio 
Di Febo Enrico 
Di Feo Antonio 
Di Fraia Giovanni 
Di Fulvio Aristide 
Di Nardo Dionisio 
Dolmetta Franco 
Donzelli Luigi 
Dughiero Fausto 
Durando Andrea 
Ercolino Luigi 
Fabbri Stelania 
Fabrizio Nicola 
Falchi Raffaello 
Fariello Ciro 
Fascendini Emilvio 
Fasulo Serenella 
Federici Laura 
Ferioli Paolo 
Ferrari Vincenzo 
Fidelbo Melchiorre 
Filetti Giuseppe 
Filippini Giovanni 
Fogher Michele 
Franchini Carlo Andrea 
Frascati Angelo 
Frignani Patrizia 
Fronteddu Pier Francesco 
Gadaleta Caldarola Gennaro 
Galantini Giovanna 
Gallicchio Nicola 
Gallina Franco 
Gallo Silvano 
Gambino Fortunato 
Gambuzza Guglielmo 
Garaffa Elio 
Garagiola Alberto 
Garofalo Remigio 
Garrone Alfonsino 
Gatta Luigi 
Gennari Massimo 
Gerace Antonio 
Geremia Maria Alessandra 
Germini Fabrizio 
Giacci Luciano 
Giannini Olivia 
Giordano Stefano 
Giovannelli Umberto 
Giuffré Giuseppe 
Giunti Giuliana 
Glaviano Bruno 
Gorletta Giovanni 
Grand Paola 
Grassini Giovanni 
Grasso Anna Maria 
Grasso Giuseppe  
Grasso Maria Filomena  
Greco Agostino 
Grifagni Marcello 
Grilli Piero 
Grimaldi Emanuela  
Grimaldi Nicola  
Grosso Marco 
Guarnera Lucia 
Guerra Antonio 
Guillaro Bruno 
Gussoni Barbara Rita 
Ianiro Gabriella 
Ilardi Salvatore 
Imbalzano Pasquale 
Inguscio Cherubino 
Invernizzi Giovanni 
Iocca Tommaso 
Kos Egidia 
La Mattina Rosolino 
La Torre Angelo 
Lacava Cosimo 
Lalli Pasqualino 
Lamera Giorgio 
Lanza Gerardo 
Lardo Gerardo 
Laringe Matteo 
Lattanzio Giuseppe 
Le Foche Luca 
Leo Rosanna 
Leuzzi Giacomo 
Lipari Antonino  
Lipari Francesco  
Lippa Luciano 
Lo Conte Maurizio 
Lo Giudice Domenico 
Lonati Rossella 
Lorenzina Enrico 
Magi Lorenzo 
Magliozzo Francesco 
Mallamo Luciano 
Mantovani Licia 
Marcenaro Alessandro 
Marchetti Anna Rosa 
Mariano Carlo 
Marino Antonino 
Mariuz Manuela 
Maroni Achille 
Martori Ampelio 
Masoch Gigliola 
Mattioli Carlo 
Mattioli Mauro 
Maurici Vincenzo 
Mauro Nicola 
Mazzardi Lidia 
Mazzi Wainer 
Mazzocchetti Alvaro 
Mazzoleni Francesco 
Mazzorana Michela 
Medagliani Giorgio 
Medea Gerardo 
Merlino Giovanni 
Merone Laura 
Metrucci Antonio 
Mezzano Silvio 
Micchi Alessio 
Micheli Pietro Severo 
Milazzo Vito 
Minafra Francesco 
Minetti Luca 
Mirandola Cipriano 
Monari Gianluigi 
Mongiello Claudio 
Montano Giovanni 
Montera Carmine 
Moretti Marino 
Morgana Ignazio 
Morganti Mauro 
Mormile Annunziata 
Moro Roberto 
Mostacciolo Francesco 
Mourglia Danilo 
Murari Tiziana 
Muratore Alessandro 
Murgia Rosalba 
Naccari Massimo 
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Napoli Luigi 
Nardacci Giuseppe 
Nebiacolombo Cristina 
Negri Fabrizio 
Nicolini Gianfranco 
Nigro Antonio 
Noia Emanuela 
Nuti Claudio Pietro 
Olivani Enrico 
Orlando Celestina 
Padovan Letizia 
Padula Maria Stella 
Pagan Maurizio 
Pannacci Valerio 
Pantalone Vincenzo 
Paolini Italo 
Papandrea Giampaolo 
Papini Giovanni 
Papulino Francesco 
Paradisi Enza 
Parisi Carmela 
Parretti Damiano 
Pasculli Domenico 
Pasinelli Pietro Carlo 
Pasqualetto Salvatore 
Passamonti Marco 
Passaro Vincenzo 
Pederzani Fabio 
Pedrazzoli Giuliano 
Pelizzari Pier Carlo 
Pernici Pierrenato 
Pesaresi Carlo 
Pesce Gian Luigi 
Petrucci Marco  
Petrucci Mauro  
Petrulli Carmela 
Petti Stefano 
Piccinocchi Gaetano 
Picciotto Rinaldo 
Piccolo Francesco 
Pierobon Ivo 
Pilone Rita 
Piva Roberto 
Pizzillo Carlo 
Plebani Franco 
Polistina Stefano 
Pontari Antonino 
Poppi Maria Cristina 
Portanti Carla 
Prencipe Giovanni 
Prestifilippo Alessandro 
Procopio Antonio 
Profeta Gaetano 
Proietti Carlo 
Quattrocchi Pietro 
Raciti Teodoro 
Ragazzoni Anna 
Rattini Emanuela 
Reale Emanuela 
Redaelli Dario 
Reggiani Claudio 
Ricotta Giuseppe 
Rigamonti Rodolfo 
Righini Velella 
Rinaldi Vanna 
Rista Pierangela 
Romano Salvatore 
Romei Federico 
Rossi Alberto 
Rossi Angelo 
Rossi Francesco 
Rossi Gianluca 
Rosso Lucia 
Rovazzani Massimo 
Rovelli Monica 
Rovescala Pietroclaudio 
Rubicini Giuseppe 
Rubini Stefano 
Russo Carolina  
Russo Vincenzo  
Sala Massimo 
Salurso Daniele 
Salvaderi Maria Dionice 
Salvato Alberto 
Salvetti Andrea 
Salvio Giuliano 
Samani Fabio 
Sammarco Renato 
Santoiemma Luigi 
Santoro Michele 
Sassarini Graziano 
Savino Andrea 
Scaglione Matteo 
Scarano Libero 
Schiavone Ciro 
Scola Vincenzo 
Scorpiniti Anna 
Scotto D’Antuono Antonio 
Scovotto Maria Antonietta 
Scuri Maurizio Giovanni 
Scuteri Antonio 
Sebastianelli Giuliano 
Sebben Maurizio 
Sforza Pasqualino 
Sfragara Ignazio 
Sicari Giuseppe 
Simonini Giorgio 
Soldani Miriam 
Soverina Patrizio 
Spagnolo Beatrice 
Sperandio Massimo 
Spezzano Alfredo 
Steri Lia 
Storni Paolo 
Strada Sonia 
Stramenga Carlo 
Tagliabue Paola Fausta 
Tarabini Legnoaura 
Tarallo Nicola 
Tei Alessandro 
Tei Gian Paolo 
Testi Sergio 
Testolin Ennio 
Tibo Angela 
Titone Nicolò 
Tomasello Antonino 
Tondi Lidia 
Torti Giorgio Tommaso 
Toscano Emanuele 
Tota Maria Fiorenza 
Tozzoli Alfonso 
Travaglini Rita 
Trois Paolo 
Trotta Gaetano 
Tuia Bruno 
Turbil Enrico 
Ughetti Claudio 
Urru Cesare 
Valdevit Maria 
Valente Fabio 
Valenti Marco 
Valle Lucia 
Valletta Domenico 
Valore Salvatore 
Varriale Antonio 
Varrica Gaetano 
Ventriglia Giuseppe 
Venturelli Antonio 
Vesco Giuseppe 
Vezzosi Angelo 
Viola Dario 
Viscusi Bruno 
Vita Salvatore 
Vitali Franco 
Vittozzi Dante Sergio 
Vivona Giacomo 
Volpe Augusto 
Volponi Damiano Antonio 
Voza Italo 
Zadra Alessandro 
Zaninetti Piero 
Zanini Riccardo 
Zennaro Walter 
Zingaro Angelo 
Zito Alfonso 
Zollino Luciana 
Zovi Maria Carla 
Zunino Roberto 
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